Chimeron Bio is applying their scientific expertise and proprietary technology to create and deliver next generation RNA therapeutics.

Their preclinical drug development pipeline is initially focused in three key therapeutic areas with high potential to deliver meaningful patient results: oncology, genetic disorders and infectious diseases.